Search ...
Copyright © 2021 CHILDRENS RARE DISEASE ORGANIZATION .
Copyright © 2021 CHILDRENS RARE DISEASE ORGANIZATION .

CHILDRENS RARE DISEASE ORGANIZATION CHILDRENS RARE DISEASE ORGANIZATION

DONATE NOW
Friday , February 3 2023
info@childrenraredisease.org
1(301)801-3271
  • Home
  • Grant
  • News
  • About Us
  • Contact Us
  • Donate
  • Rare Disease Drug Development
    • Children’s Rare Diseases and Disease Search
    • FDA rare pediatric disease designation and awards
    • Priority review voucher
  • Join Us
  • Search
  • 0Cart
  • Menu

CHILDRENS RARE DISEASE ORGANIZATION

  • Home
  • Grant
  • News
  • About Us
  • Contact Us
  • Donate
  • Rare Disease Drug Development
    • Children’s Rare Diseases and Disease Search
    • FDA rare pediatric disease designation and awards
    • Priority review voucher
  • Join Us
  • 0Cart
  • Menu
DONATE NOW

CDC

HomeCDC

Rare Disease Institute in Children’s National Hospital now is seeing patients at their their new location on the Research & Innovation Campus, 7125 13th Pl NW Washington, DC 20012.


  • April 20, 2021 December 8, 2021 By childrenraredisease
  • CDC
Rare Disease Institute - Genetics and Metabolism | Children's National Hospital

National Organization for Rare Disorders (NORD) will host Rare Disease Breakthrough Summit on Oct 18-19 this year.


  • January 20, 2021 December 8, 2021 By childrenraredisease
  • CDC
Please check Summit Event Details - NORD (National Organization for Rare Disorders) (rarediseases.org)  for details. Have a go with ones luck is known as a die online game online games casino.   Rare Diseases and Orphan Products Breakthrough Summit October 18-19, 2021 2020 Summit Pricing *2021 Pricing and dates subject to change   Early Bird (ends 8/27/2021) Standard NORD Patient Organization Members $185 $345 Registered 501c3...

You can search any pediatric rare disease designation at FDA database


  • January 20, 2021 December 8, 2021 By childrenraredisease
  • CDC
Search Orphan Drug Designations and Approvals (fda.gov)

FDA Approves First Treatment for Rare Genetic Metabolic Pediatric Disorder (ajmc.com)


  • April 21, 2020 December 8, 2021 By childrenraredisease
  • CDC
FDA Approves First Treatment for Rare Genetic Metabolic Pediatric Disorder (ajmc.com) The disorder known as molybdenum cofactor deficiency (MoCD) Type A presents shortly after birth, often with severe encephalopathy and intractable seizures. The FDA approved the first therapy for an ultra-rare genetic metabolic disorder that affects infants, who don’t normally live past the age of 4. The disorder is...
About

Children’s rare disease organization provides free seed fund to boost research in this field. The goal is to identify treatments to meet the current unmet need for pediatric rare diseases.

Contact us

If you would like to join us, contribute to our current projects or have any suggestions, please contact us.
Phone: 1(301)801-3271
Email: info@childrenraredisease.org
Subscribe

Subscribe to our email newsletter.
Copyright © 2021 CHILDRENS RARE DISEASE ORGANIZATION .